Skip to main content
OpenTrials
Completed

NCT Number: NCT04841772

Exploring Muscle Breakdown During Exercise Recovery

This study will allow researchers to explore how muscle responds to heavy exercise. The researchers will characterise rates of muscle protein breakdown and synthesis 24hours after heavy exercise with a post exercise protein polyphenol or placebo supplementation. This will inform strategies to help people recover from heavy exercise.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Exeter

Exeter, Devon, EX1 2LU, United Kingdom

About this study

It is well known that resistance exercise increases rates of muscle protein synthesis and breakdown, with the rise in synthesis greater in magnitude and duration. The time course of rates of muscle protein synthesis increase dramatically 24-72h following eccentric exercise, even in a non-exercised control leg. This data is consistent with a much larger increase in muscle protein breakdown than previously thought. However, the response of muscle protein breakdown following damaging eccentric exercise, and its relationship with muscle protein synthesis, has not yet been elucidated. Moreover, it is unclear whether a protein and polyphenol nutritional intervention influence rates of muscle protein breakdown to accelerate recovery. This study will allow researchers to test the hypothesis that eccentric exercise increases rates of muscle protein breakdown independently of muscle contraction per se. If this hypothesis is supported, it will highlight that recovery strategies from muscle damage should also target supporting muscle protein breakdown.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Recreationally active
  • 18-40 years of age

Exclusion criteria

  • Regular and structured involvement in resistance training
  • Inactive participants
  • Habitual dietary protein intake <0.8g/kg bw/day and >2.0g/kg bw/day
  • Regular use of nutritional supplements known to suppress inflammation or modulate protein metabolism Any diagnosed metabolic conditions (diabetes), cardiovascular disease or hypertension
  • Current musculoskeletal injury
  • Chronic use of anti-inflammatory medicines
  • Any known disorders in muscle metabolism
  • Individuals with an allergy to egg, fish, wheat or soy ingredients as the product is manufactured in a facility that contains these ingredients
  • Allergy to lidocaine
  • Having received or ingested a stable isotope tracer containing 15N in the past
  • A personal or family history of epilepsy, seizures or schizophrenia
  • Stomach bleeding or stomach ulcer
  • Kidney failure
  • Liver problems, such as fibrosis, cirrhosis or failure
  • Crohns disease or ulcerative colitis
  • Chickenpox or shingles
  • Pregnant or trying to get pregnant
  • Any diagnosed cardiovascular disease (e.g. deep vein thrombosis) or hypertension.
  • Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
  • Recent (within the last 6 months) or current musculoskeletal injury (leg fracture)

Treatment and study plan

Recover Vegan Protein Supplement

Dietary Supplement

Post exercise protein supplement (26g pea protein)

Placebo

Dietary Supplement

Post exercise placebo supplement (32g maltodextrin)

Primary outcomes

  1. Muscle protein breakdown rate

    Time frame: 1hour

    Muscle protein breakdown rate (FBR, measured in %/h) 24hours post eccentric exercise.

Secondary outcomes

  1. Muscle protein synthesis rate

    Time frame: 3hours

    Muscle protein synthesis rate (FSR, measured in %/h) 24hours post eccentric exercise.

Sponsors and collaborators

Lead sponsor

University of Exeter

Other

Collaborators

  • Beachbody

Registry information

Acronym: EMBER

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Apr 12, 2021
Registry last updated
Mar 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.